scholarly article | Q13442814 |
P50 | author | Carlos Cordon-Cardo | Q11912384 |
Veronica Rodriguez-Bravo | Q57052121 | ||
P2093 | author name string | Yixuan Gong | |
Matthew Galsky | |||
William Oh | |||
Josep Domingo-Domenech | |||
Estrelania S Williams | |||
Uma Chippada-Venkata | |||
Janis De Ia Iglesia-Vicente | |||
P2860 | cites work | Patient-derived tumor xenografts: transforming clinical samples into mouse models | Q24627425 |
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes | Q24630783 | ||
Circulating tumor cells: approaches to isolation and characterization | Q24631347 | ||
Efficient tumour formation by single human melanoma cells | Q24648938 | ||
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer | Q27853127 | ||
Cancer statistics, 2013 | Q27860762 | ||
Patient-derived xenograft models: an emerging platform for translational cancer research | Q34205518 | ||
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice | Q34420980 | ||
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. | Q35174681 | ||
Biology, detection, and clinical implications of circulating tumor cells | Q38268371 | ||
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. | Q39279366 | ||
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients | Q39539819 | ||
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. | Q48001140 | ||
P433 | issue | 105 | |
P921 | main subject | patient | Q181600 |
prostate cancer | Q181257 | ||
xenograft | Q64148587 | ||
P304 | page(s) | 53182 | |
P577 | publication date | 2015-10-20 | |
P1433 | published in | Journal of Visualized Experiments | Q954500 |
P1476 | title | Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells |
Q47126156 | Blood-based tumor biomarkers in lung cancer for detection and treatment. |
Q39109584 | Circulating Tumor Cells: Fluid Surrogates of Solid Tumors. |
Q30363234 | Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection. |
Q28070333 | Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back |
Q55059491 | Cultured circulating tumor cells and their derived xenografts for personalized oncology. |
Q89993964 | Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research |
Q33667686 | Current status and perspectives of patient-derived xenograft models in cancer research |
Q91740895 | Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity |
Q58695604 | EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer |
Q39095733 | Interrogating open issues in cancer precision medicine with patient-derived xenografts. |
Q55187959 | Liquid biopsy in pancreatic cancer: the beginning of a new era. |
Q55515873 | Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. |
Q60623955 | Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import |
Q90403243 | Past, Current, and Future of Immunotherapies for Prostate Cancer |
Q52311090 | Patient-derived xenograft models in musculoskeletal malignancies. |
Q38714374 | Patient-derived xenografts as in vivo models for research in urological malignancies |
Q88189997 | Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells |
Q89774855 | The Functions of Circulating Tumor Cells in Early Diagnosis and Surveillance During Cancer Advancement |
Q64892345 | The biology and clinical potential of circulating tumor cells. |
Q49220712 | The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer |
Q39031157 | The promise of circulating tumor cells for precision cancer therapy |
Q55148658 | Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field. |
Search more.